Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,786,930
+$487,172 QoQ
Shares Held
15,049
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#1,491
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SevenBridge Financial Group, LLC holds $35,490,451 across 9 Drug Manufacturers - General names. ABBV ranks #3 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
43,610 | $11,075,631 | |
| 2 | LLY |
ELI LILLY & Co
|
8,963 | $10,750,491 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
15,049 | $3,786,930 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,263 | $3,246,295 | |
| 5 | AMGN |
Amgen Inc
|
7,381 | $2,672,807 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
21,619 | $1,245,686 | |
| 7 | NVS |
Novartis AG
|
7,267 | $1,138,884 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,580 | $831,317 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,786,930 | 15,049 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,299,758 | 15,172 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,521,487 | 15,412 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $3,585,859 | 15,487 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,283,803 | 17,691 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $3,956,366 | 18,883 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,638,229 | 20,474 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,125,752 | 20,892 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,521,134 | 20,529 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,689,528 | 20,261 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,164,642 | 20,421 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $3,057,071 | 20,509 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,707,264 | 20,094 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $3,182,300 | 19,968 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $3,164,000 | 19,578 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $2,606,760 | 19,423 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,762,565 | 11,508 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,867,669 | 11,521 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $1,782,676 | 13,166 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,218,715 | 11,298 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,306,736 | 11,601 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,176,243 | 10,869 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,112,752 | 10,385 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $748,894 | 8,550 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $825,497 | 8,408 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $661,938 | 8,688 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||